본문으로 건너뛰기
← 뒤로

A review of the treatment of male pattern hair loss.

4/5 보강
Expert opinion on pharmacotherapy 📖 저널 OA 11.1% 2021: 2/5 OA 2022: 1/5 OA 2023: 1/8 OA 2024: 1/10 OA 2025: 2/14 OA 2026: 1/13 OA 2021~2026 2020 Vol.21(5) p. 603-612 피인용 60회 cited 165 RCR 8.76 Hair Growth and Disorders
TL;DR The authors review the pharmacologic treatment of androgenetic alopecia, which involves 5 alpha reductase inhibitors, minoxidil and prostaglandins and non-pharmacologic approaches are also explored.
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-05-06
📑 코퍼스 인용 관계 · 인용됨 60
📑 인용한 논문 (6) ▾
연도별 인용 (2020–2026) · 합계 165
OpenAlex 토픽 · Hair Growth and Disorders Cancer and Skin Lesions Dermatologic Treatments and Research

York K, Meah N, Bhoyrul B, Sinclair R

관련 도메인

↔ 함께 자주 등장하는 논문 6 — 같은 위키 또는 NER 엔티티 공유

Abstract

: Androgenetic alopecia is a common hair loss disorder affecting up to 80% of males by the age of 80. It is characterized by androgen related progressive thinning of hair in a defined pattern. It results in diminished self-esteem, reduced confidence and distress in affected men, irrespective of age or stage of baldness. An effective treatment for hair baldness is needed.: In androgenetic alopecia, hair follicles undergo progressive miniaturization. Genetic factors and androgens are key role-players in disease pathogenesis. Herein the authors review the pharmacologic treatment of androgenetic alopecia, which involves 5 alpha reductase inhibitors, minoxidil and prostaglandins. Non-pharmacologic approaches are also explored.: Androgenetic alopecia progresses over time and although the current available medical treatments like finasteride and minoxidil are effective in arresting the progression of the disease, they allow only partial regrowth of hair at its best. Early treatment achieves a more optimal outcome. Non-pharmacologic treatments like PRP can be considered in patients refractory to medical treatment. MPHL: male pattern hair loss; AGA: androgenetic alopecia; DHT: dihydrotestosterone; 5AR: 5-alpha-reductase; VEGF: vascular endothelial growth factor; PG's: prostaglandins (PG's); PGD2R: prostaglandin D2 receptor; VPA: valproic aid; SR: Serenoa Repens; PRP: platelet-rich plasma; PDGF: platelet derived growth factor; TGF: transforming growth factor; ERK: extracellular signal-regulated kinase; PKB: protein kinase B; LLLT: low-level laser therapy; ROS: reactive oxygen species; RCT: randomized control trial; SFRP1: secreted frizzled related protein 1; DP: dermal papilla; PDE5: phosphodiesterase 5.
🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 연구 설계 RCT
📝 환자 설명용 한 줄

The authors review the pharmacologic treatment of androgenetic alopecia, which involves 5 alpha reductase inhibitors, minoxidil and prostaglandins and non-pharmacologic approaches are also explored.

이 논문을 인용하기

↓ .bib ↓ .ris
APA 7 York, K., Meah, N., Bhoyrul, B., & Sinclair, R. (2020). A review of the treatment of male pattern hair loss.. Expert opinion on pharmacotherapy, 21(5), 603-612. https://doi.org/10.1080/14656566.2020.1721463
Vancouver York K, Meah N, Bhoyrul B, Sinclair R. A review of the treatment of male pattern hair loss. Expe. opin. phar.. 2020;21(5):603-612. doi:10.1080/14656566.2020.1721463
AMA 11 York K, Meah N, Bhoyrul B, Sinclair R. A review of the treatment of male pattern hair loss. Expe. opin. phar.. 2020;21(5):603-612. doi:10.1080/14656566.2020.1721463
Chicago York, K., Meah, N., Bhoyrul, B., and Sinclair, R.. 2020. "A review of the treatment of male pattern hair loss." Expert opinion on pharmacotherapy 21 (5): 603-612. https://doi.org/10.1080/14656566.2020.1721463
MLA 9 York, K., et al. "A review of the treatment of male pattern hair loss." Expert opinion on pharmacotherapy, vol. 21, no. 5, 2020, pp. 603-612. doi:10.1080/14656566.2020.1721463.
PMID 32066284 ↗

추출된 의학 개체 (NER)

전체 NER 표 보기
유형영어 표현한국어 / 풀이UMLS CUI출처등장
질환 androgenetic alopecia 안드로겐성 탈모 dict 5
약물 minoxidil 미녹시딜 dict 2
질환 male pattern hair loss 남성형 탈모 dict 2
약물 finasteride 피나스테리드 dict 1
약물 finasteride 피나스테리드 dict 1
약물 finasteride 피나스테리드 dict 1

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

인용 관계

그래프 OA 노드: 8/8 (100%) · 참조 0편 · 후속 8편

이 논문을 인용한 후속 연구 20

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능